Mechanical CPR Devices Show No Survival Benefit in Large US Registry Study
A major registry study finds mechanical CPR devices did not improve cardiac arrest survival or neurological outcomes at EMS agencies.
Summary
A large observational study using the Cardiac Arrest Registry to Enhance Survival (CARES) examined whether mechanical CPR devices improved out-of-hospital cardiac arrest outcomes across 49 EMS agencies. Researchers compared survival rates before and after agencies introduced these devices between 2013 and 2019. Despite widespread adoption and the intuitive appeal of consistent, machine-delivered compressions, favorable neurological survival and survival to discharge rates did not improve after device introduction. In fact, rates were slightly lower after adoption, though not statistically significant. With 73 control agencies showing stable baseline trends, the interrupted time series analysis found no meaningful change in either survival metric. These findings challenge the assumption that mechanical CPR devices translate laboratory-quality compressions into real-world survival gains.
Detailed Summary
Cardiac arrest remains one of the most time-critical emergencies in emergency medicine, and high-quality CPR is foundational to survival. Mechanical CPR devices have been marketed as a solution to the inconsistent, fatiguing compressions delivered by human responders — promising machine-perfect chest compressions throughout resuscitation. Yet whether this theoretical advantage translates to real-world survival has remained uncertain.
This study used the Cardiac Arrest Registry to Enhance Survival (CARES), one of the largest US registries of out-of-hospital cardiac arrest (OHCA), to evaluate 49 EMS agencies that adopted mechanical CPR devices between 2013 and 2019. Researchers assessed agency-level outcomes at least two years before and after first device use, comparing against 73 control agencies that never adopted the technology.
Control agencies showed stable survival trends throughout the study period — favorable neurological survival ranged between 9.6% and 10.6% annually with no significant trend. Among agencies adopting mechanical CPR devices, favorable neurological survival was 8.9% before and 8.3% after introduction, while survival to discharge was 11.0% before and 10.0% after. Interrupted time series analysis found no statistically significant change in either the level or trajectory of survival rates following device adoption.
These findings have important implications for EMS resource allocation. Mechanical CPR devices are expensive, require training, and can introduce interruptions during placement. If real-world survival does not improve, the cost-benefit calculus may not favor universal adoption.
Caveats include the observational design, which cannot fully account for confounding — agencies that adopted devices may differ systematically from those that did not. Additionally, this analysis reflects agency-level averages, not individual patient-level device usage, and cannot assess whether specific subgroups might benefit. The summary is based on the abstract only.
Key Findings
- Mechanical CPR device adoption at 49 EMS agencies was not associated with improved neurological survival or survival to discharge.
- Favorable neurological survival was 8.9% pre-device vs. 8.3% post-device — a non-significant decline.
- 73 control agencies showed no temporal survival trends, providing a stable comparator across the same period.
- Interrupted time series found no significant change in survival slope or intercept after device introduction.
- Findings challenge widespread EMS investment in mechanical CPR devices without evidence of real-world benefit.
Methodology
Observational cohort study using CARES registry data from 2013–2019, comparing 49 EMS agencies before and after mechanical CPR device adoption against 73 control agencies. Multivariable hierarchical logistic regression assessed temporal trends; interrupted time series analysis evaluated changes in survival following device introduction. Risk-adjusted agency-level outcomes were the primary endpoints.
Study Limitations
The observational design cannot exclude confounding — EMS agencies choosing to adopt devices may differ in training, patient populations, or system quality. Analysis is at the agency level rather than individual patient level, so device use rates and patient-specific application are not captured. The summary is based on the abstract only, limiting assessment of full methodological detail and subgroup analyses.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: